While artificial intelligence may be useful for a variety of purposes – including asking silly questions we're afraid to pose in real life – the ultimate end game for digital intelligence could be to advance the human condition, which brings us to medical AI stocks. When conducted in a controlled environment, AI can help accelerate productivity.
The medical device maker's growth rate has averaged less than 2% in the past five years. However, it's still innovating and recently launched an AI-assisted endoscopy system.
According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues DUBLIN , April 17, 2024 /PRNewswire/ -- Americans overwhelmingly say that when they think about longevity, it's more than just living longer—it's about living their healthiest, best lives. While most want to live to 90—w...
Although dividend investing has plenty of research backing its efficacy, it's a slow burn. Further, it may incur high opportunity costs during broad-market rallies, such as what we saw during the bull in the Nasdaq last year.
AI could solve one of the biggest problems in drug development: the lengthy time it takes to bring a product to market. The AI in healthcare market is set to expand at a compound annual growth rate of nearly 50%.
Medtronic is a healthcare technology company that has seen encouraging growth in the current fiscal year. The company has maintained pricing power and has a strong balance sheet, with an A+ grade for profitability. Medtronic is well-positioned for future opportunities, including diabetes care, and is undervalued compared to historical norms with a decent starting dividend yield.
Medtronic is undervalued compared to its long-term P/E ratio and has potential for strong returns. The company's focus on innovation and product diversification positions it well for future growth.
Dividend stocks are finally cycling back into portfolios after a few years' worth of higher interest rates put fixed-income options ahead of dividend distribution yield for income investors. As those investors circle back toward dividend stocks, a few things have changed about how to best look at the many available offerings – but that's true for most stock segments today.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.